OPEN END TURBO LONG - IQVIA HOLDINGS Stock

Certificat

DE000MG3CJC4

Real-time Bid/Ask 05:00:12 2024-07-09 am EDT
6.1 EUR / 6.39 EUR +1.38% Intraday chart for OPEN END TURBO LONG - IQVIA HOLDINGS
Current month-4.35%
1 month-14.56%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes
Date Price Change
24-07-09 6.08 -1.30%
24-07-08 6.16 +1.65%
24-07-05 6.06 +2.89%
24-07-04 5.89 -0.67%
24-07-03 5.93 -3.10%

Delayed Quote Börse Stuttgart

Last update July 09, 2024 at 02:54 am EDT

More quotes

Static data

Product typeKnock-Out without Stop Loss
Buy / SellCALL
Underlying IQVIA HOLDINGS INC.
Issuer Morgan Stanley
WKN MG3CJC
ISINDE000MG3CJC4
Date issued 2024-04-30
Strike 142.7 $
Maturity Unlimited
Parity 10 : 1
Emission price 8.93
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 8.94
Lowest since issue 5.88
Spread 0.29
Spread %4.54%

Company Profile

Iqvia Holdings Inc. is one of the world's leading companies specializing in information, analytics, research and healthcare services based on technology solutions. Net sales break down by activity as follows: - development of contract research and clinical development solutions and services (54.5%): helping biopharmaceutical companies, medical researchers and healthcare professionals optimize their clinical studies, develop new therapeutic classes, identify treatment needs and assess the efficacy of pharmaceuticals with a view to improving clinical and scientific outcomes; - development of technology and analytics solutions (39.9%): services related to information, analysis, strategic consulting, marketing studies and short-term healthcare-market studies, business processes outsourcing, and management of medical-administrative databases, all aimed at optimizing the performance and commercial strategies of pharmaceutical companies and health workers; - integrated services (5.6%): development and implementation of customized solutions and customer engagement programs, healthcare services, scientific and medical services, etc. Net sales are distributed geographically as follows: Americas (49.4%), Europe and Africa (31.4%) and Asia/Pacific (19.2%).
Sector
-
More about the company

Ratings for Iqvia Holdings Inc.

Trading Rating
Investor Rating
ESG Refinitiv
B
More Ratings

Consensus: Iqvia Holdings Inc.

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
23
Last Close Price
208.9 USD
Average target price
270.5 USD
Spread / Average Target
+29.49%
Consensus